MELTDOSE
DEAD

Serial Number

78219715

Owner

VELOXIS PHARMACEUTICALS A/S

Attorney

Julia Anne Matheson

Filing Date

Feb 27, 2003

Add to watchlist:

No watchlists yet
View on USPTO

MELTDOSE Trademark

Serial Number: 78219715 • Registration: 2959361

MELTDOSE is a trademark filed by VELOXIS PHARMACEUTICALS A/S on February 27, 2003. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

VELOXIS PHARMACEUTICALS A/S (27 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOLM , DK

Entity Type: 99

Veloxis Pharmaceuticals, Inc. (12 trademarks)

2000 Regency Parkway,

Entity Type: 99

LIFE CYCLE PHARMA A/S (2 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOOLM , DK

Entity Type: 03

Pharotech A/S (6 trademarks)

Ottiliavej 9
Valby 2500 , DK

Entity Type: 03

Trademark Details

Filing Date

February 27, 2003

Registration Date

June 7, 2005

Published for Opposition

March 15, 2005

Cancellation Date

December 19, 2025

Goods & Services

[ Scientific research, namely, bacteriological research, biological research, biotechnological research, scientific research services for medical purposes and scientific research consultation; research and development for new products for others; industrial design services; pharmaceutical and medical consultation regarding pharmaceutical drug development services; cosmetic research for others; design services for others in the field of medical packaging and equipment; medical research; medical and scientific research, namely, conducting clinical trials, namely, testing of medical substances and testing of medical applications; pharmaceutical drug development services, namely, development of medical applications, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations and consultation regarding pharmaceutical formulation; ] development of drug delivery systems for others, namely, development of solid dosage forms, pharmaceutical controlled release systems, modified release systems and pharmaceutical modified release systems and consultation related thereto; [ pharmaceutical drug development services, namely, development of mixing technology, development of particulate material, development of particulate material mixing technology, development of granulate technology, development of tabletting technology, and consultation related thereto ]

[ Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical, and pharmaceutical fields ]

[ Pharmaceutical preparations; medical preparations; and drug delivery systems, ] pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, pills, sachets, powders, and capsules; ] all of the above for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, ] diseases of [ the heart and ] blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, ] diseases of the blood, [ infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Dec 19, 2025 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 7, 2024 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 21, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 21, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 21, 2023 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 8, 2021 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 28, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 28, 2017 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 10, 2015 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jun 10, 2015 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Jun 10, 2015 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Jun 10, 2015 8PRT
TEAS SECTION 8 & 9 RECEIVED
Jun 4, 2015 E89R
NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
Dec 19, 2011 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Dec 19, 2011 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 16, 2011 APRE
REGISTERED - SEC. 8 (6-YR) FILED
Dec 7, 2011 8.AF
TEAS SECTION 8 RECEIVED
Dec 7, 2011 ES8R
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 23, 2011 ASGN
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2005 R.PR
PUBLISHED FOR OPPOSITION
Mar 15, 2005 PUBO
NOTICE OF PUBLICATION
Feb 23, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 29, 2004 PREV
PAPER RECEIVED
Dec 29, 2004 MAIL
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2004 CNSA
ASSIGNED TO LIE
Aug 27, 2004 ALIE
ASSIGNED TO LIE
Aug 25, 2004 ALIE
EXAMINER'S AMENDMENT ENTERED
Aug 24, 2004 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 24, 2004 GNEA
FINAL REFUSAL MAILED
May 19, 2004 CNFR
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 10, 2004 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2004 CNSA
Sec. 1(B) CLAIM DELETED
Feb 19, 2004 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2004 CRFA
PAPER RECEIVED
Feb 19, 2004 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2004 TCCA
NON-FINAL ACTION E-MAILED
Aug 25, 2003 GNRT
ASSIGNED TO EXAMINER
Aug 20, 2003 DOCK